Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia X in dogs is a cosmetic issue, not a hormonal disorder, and harmful treatments should be avoided.

Mothers and newborns with dental fillings have higher mercury in their hair, but adding fillings during pregnancy doesn't raise mercury levels further.

Finasteride significantly increases scalp hair and prevents hair loss in young and middle-aged men.

Changing protein kinase levels in pituitary cells affects calcium flow and beta-endorphin release.

Hair loss caused by genetics and hormones; more research needed for treatments.

Fluridil safely promotes hair growth in men with androgenetic alopecia.

Tributyltin exposure causes sex changes, sterilization, and decline in the snail Ocinebrina aciculata, risking its extinction.

New treatments for male hypogonadism are effective and should be personalized.

Pregnancy reduces anxiety in rats, but finasteride reverses this effect.

TECAR therapy helps with pain relief, reduces inflammation, relaxes muscles, heals tissues, and is safe and effective for many conditions.

Tofacitinib is a promising treatment for children with rheumatic diseases.

TAF4 is important for skin cell growth and helps prevent skin cancer in mice.

Tenofovir alafenamide fumarate is effective and safer for hepatitis B, with fewer side effects than tenofovir disoproxil fumarate.

Teprotumumab for thyroid eye disease commonly causes fatigue, brittle nails, dry eyes, hair loss, muscle spasms, and dry mouth, with rare serious events like blood clots.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

HGF combined with ADA is highly accurate for diagnosing tuberculous pleural effusion, especially in younger females.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

An intact skin barrier is crucial to prevent infection in cases of tether-induced tenosynovitis.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Tofacitinib treatment is used for teenagers with alopecia areata.

Telogen effluvium is a common hair loss condition requiring careful diagnosis and treatment.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Phosphorylation controls TFEB's location in the cell, affecting cell metabolism and stress response.

Tofacitinib effectively improved severe skin symptoms in a patient with Hypohidrotic Ectodermal Dysplasia.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

The TO-TF copolymer strengthens damaged hair effectively and sustainably.

Tofacitinib taken by mouth helps treat hair loss in children.